Top Suppliers:I want be here


1210344-57-2

1210344-57-2 structure
1210344-57-2 structure
  • Name: Ertugliflozin
  • Chemical Name: (1S,2S,3S,4R,5S)-5-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol
  • CAS Number: 1210344-57-2
  • Molecular Formula: C22H25ClO7
  • Molecular Weight: 436.883
  • Catalog: API Hormone and endocrine-regulating drugs Pancreatic hormones and other blood sugar regulating drugs
  • Create Date: 2018-05-14 08:00:00
  • Modify Date: 2026-06-30 13:47:19
  • Ertugliflozin (PF-04971729) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2[1]. A drug for the treatment of type 2 diabetes mellitus[2].

Name (1S,2S,3S,4R,5S)-5-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol
Synonyms (1S,2S,3S,4R,5S)-5-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol
PF04971729;PF 04971729 (ERTUGLIFLOZIN)
(1S,2S,3S,4R,5S)-(2,3,4-TRIS-BENZYLOXY-5-(4-CHLORO-3-(4-ETHOXY-BENZYL)-PHENYL)-68-DIOXA-BICYCLO(3.2.1)OCT-1-YL)-METHANOL
agliflozin
1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-beta-L-idopyranose PF-04971729(Ertugliflozin)
(1S,2S,3S,4R,5S)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol
Feline Diabetes SGLT2 Inhibitor Intermediate
Ertugliflozin Intermediate PF05
Leuco methylthioninium
Ertugliflozin MK-8835
PF 04971
(1S,2S,3S,4R,5S)-5-[4-chloro-3-(4-ethoxybenzyl)phenyl]-1-hydroxymethyl-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol
Ertugliflozin/PF-04971729
MK-8835, PF-04971729
Ertugliflozin, >=
Ertugliflozin : PF 04971
Ertugliflozin D4
Ertugliflozin (USAN/INN)
Leuco methylthioninium Impurity
cc-212
Ertuglifozin
ERTUGLIFLOZIN;PF04971729;PF
β-L-Idopyranose, 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)
PF-04971729/Ertugliflozin
Ertugliflozin, 10 mM in DMSO
PF-04971729-00
PF-04971729 //BP
1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-β-L-idopyranose
PF-04971729/PF04971729
PF-04971729
Ertugliflozin Base
1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-beta-L-idopyranose
PF-4971729)
Empagliflozin Impurity
MK-8835
Description Ertugliflozin (PF-04971729) is a potent, selective and orally active inhibitor of the sodium-dependent glucose cotransporter 2 (SGLT2), with an IC50 of 0.877 nM for h-SGLT2[1]. A drug for the treatment of type 2 diabetes mellitus[2].
Related Catalog
Target

IC50: 0.877 nM (h-SGLT2)[1].

In Vitro Ertugliflozin (PF-04971729) demonstrates >2000-fold selectivity for SGLT2 inhibition (relative to SGLT1) in vitro[3].
In Vivo Ertugliflozin (PF-04971729) reveals a concentration-dependent glucosuria after oral administration to rats[3].
References

[1]. Mascitti V, et al. Discovery of a clinical candidate from the structurally unique dioxa-bicyclo[3.2.1]octane class of sodium-dependent glucose cotransporter 2 inhibitors. J Med Chem. 2011 Apr 28;54(8):2952-60.

[2]. Miao Z, et al. Pharmacokinetics, metabolism, and excretion of the antidiabetic agent ertugliflozin (PF-04971729) in healthy male subjects. Drug Metab Dispos. 2013 Feb;41(2):445-56.

[3]. Kalgutkar AS, et al. Preclinical species and human disposition of PF-04971729, a selective inhibitor of the sodium-dependent glucose cotransporter 2 and clinical candidate for the treatment of type 2 diabetes mellitus. Drug Metab Dispos. 2011 Sep;39(9):1609-19.

Density 1.5±0.1 g/cm3
Boiling Point 630.5±55.0 °C at 760 mmHg
Molecular Formula C22H25ClO7
Molecular Weight 436.883
Flash Point 335.1±31.5 °C
Exact Mass 436.128876
PSA 108.61000
LogP 6.49
Vapour Pressure 0.0±1.9 mmHg at 25°C
Index of Refraction 1.652
Storage condition -20℃

~28%

1210344-57-2 structure

1210344-57-2

Literature: WO2010/23594 A1, ; Page/Page column 64-66 ;

~%

1210344-57-2 structure

1210344-57-2

Literature: Organic Letters, , vol. 12, # 13 p. 2940 - 2943
Precursor  2

DownStream  0

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.